Nordic Capital and Avista Capital Partners are to partially exit medical products company ConvaTec via a flotation on the London Stock Exchange in a deal that values the company at around $7.2bn.
Tag Archives | IPO
The firm originally acquired Solasto Corporation in 2012, and will sell a maximum of 40 percent of its shares.
The IPO of the pharma firm was heavily oversubscribed and is the first on the Tunis Stock Exchange this year.
Biotech stood alone in the first quarter as the only sector to achieve US venture-backed IPOs. Why is it so resilient?
There were six venture-backed IPOs on US markets in Q1, and all of those were for biotech companies.
CX Partners is among a number of firms hoping to take advantage of high market valuations, by taking diagnostic services provider Thyrocare public in the second quarter of 2016.
Amitava Ghosal, chief executive officer of Al Masah’s healthcare investment arm Avivo Group, talks about the challenges and opportunities of investing in healthcare in the Gulf region and the firms’ expansion and listing plans.
The private equity firms have sold some of their stakes in the low-cost gym operator through an initial public offering on the London Stock Exchange that values the company at £250 million.
The ambulatory surgical network has filed for an initial public offering, planning to sell $400 million in common stock.
Of the 16 healthcare IPOs during the first quarter, 14 were venture capital-backed companies.